WuXi PharmaTech, a pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the US, has appointed Edward Hu as chief financial officer (CFO). Hu has served as the company’s chief operating officer (COO) since January 2008 and previously served as acting CFO from February 2009 through May 2010. Hao Zhou, the current CFO, is leaving WuXi to pursue other opportunities and will assist in the transition.
UK firms investment in training and development will increase, on average, by a fifth in the next year, claims Robert Half recruitment after interviewing 100 financial services (FS) executives.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.